Healthcare Sales & Marketing Network News: denileukin diftitox

Searching News Database: denileukin diftitox

HSMN NewsFeed - 8 Sep 2023
Citius Pharmaceuticals, Inc. Receives Regulatory Guidance from the U.S. Food and Drug Administration (FDA) regarding the Planned Resubmission of the BLA for LYMPHIR(TM)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 4 Jun 2007
ONTAK(R) (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Oct 2006
Ligand Completes Sale of Oncology Product Lines
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 25 Oct 2006
Eisai Announces Completion of Acquisition of Four Oncology-Related Products from Ligand
Biopharmaceuticals Oncology Acquisitions

Return to NewsFeed

Additional items found! 9

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 9 additional stories matching:
denileukin diftitox
(Password required)

FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!